Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet

Transplant Infectious Disease

Volumn 12, Issue 5, 2010, Pages 437-440

  Lagadinou, E D ^a   Marangos, M ^a   Liga, M ^a   Panos, G ^a   Tzouvara, E ^a   Dimitroulia, E ^b   Tiniakou, M ^a   Tsakris, A ^b   Zoumbos, N ^a   Spyridonidis, A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Allogeneic hematopoietic cell transplant; Foscarnet; Foscavir; HCT; HHV 6; PRCA; Severe immune suppression

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOSCARNET; METHOTREXATE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; ERYTHROCYTE APLASIA; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; PANCYTOPENIA; PRIORITY JOURNAL; SUPERINFECTION; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; FOSCARNET; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNE TOLERANCE; MALE; RED-CELL APLASIA, PURE; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD;

EID: 78650549247     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00515.x     Document Type: Article

References (20)

1. Ljungman P, De La Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42 (4): 227-240.
2. Dziecia{ogonek}tkowski T, Przybylski M, Torosian T, Tomaszewska A, Łuczak M. Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience. Arch Immunol Ther Exp 2008; 56: 201-206.
3. Ljungman P, Singh N. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 2006; 37 (Suppl 1): S87-S91.
4. Kamble RT, Clark DA, Leong HN, Heslop HE, Brenner MK, Carrum G. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 563-566.
5. Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 705-707.
6. Johnston RE, Geretti AM, Prentice G, Clark D, Wheeler AC, Potter M. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Hematol 1999; 105: 1041-1043.
7. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167 (3): 735-739.
8. Jeulin H, Salmon A, Gautheret-Dejean A, et al. Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation. J Clin Virol 2009; 45 (1): 43-46.
9. Ogata M, Satou T, Kawano R, et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008; 41: 279-285.
10. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994; 84 (10): 3307-3310.
11. Carrigan DR, Knox KK. Bone marrow suppression by human herpesvirus-6: comparison of the A and B variants of the virus [letter; comment]. Blood 1995; 86 (2): 835-836.
12. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin Infect Dis 1996; 22 (1): 174-175.
13. Imbert-Marcille BM, Tang XW, Lepelletier D, et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000; 31 (4): 881-886.
14. Penchansky L, Jordan JA. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 1997; 108 (2): 127-132.
15. Dockrell DH. Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol 2003; 52 (Part 1): 5-18.
16. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992; 165 (5): 925-929.
17. Isomura H, Yamada M, Yoshida M, et al. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997; 52 (4): 406-412.
18. Dockrell DH, Prada J, Jones MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997; 176: 1135-1140.
19. Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000; 69: 2566-2573.
20. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 2006; 37 (Suppl 1): 4-10.